| Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS). Dowdell K.C., Pesnicak L., Hoffmann V., Steadman K., Remaley A.T., Cohen J.I., Straus S.E., Rao V.K.
Exp. Hematol. 37:487-494(2009) · Mapped (3) |
| Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib. Bi L.L., Pan G., Atkinson T.P., Zheng L., Dale J.K., Makris C., Reddy V., McDonald J.M., Siegel R.M., Puck J.M. et al.
BMC Med. Genet. 8:41-41(2007) · Mapped (3) |
| NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Oliveira J.B., Bidere N., Niemela J.E., Zheng L., Sakai K., Nix C.P., Danner R.L., Barb J., Munson P.J., Puck J.M. et al.
Proc. Natl. Acad. Sci. U.S.A. 104:8953-8958(2007) · UniProtKB (1) · Mapped (4) |
| Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome. Zhu S., Hsu A.P., Vacek M.M., Zheng L., Schaeffer A.A., Dale J.K., Davis J., Fischer R.E., Straus S.E., Boruchov D. et al.
Hum. Genet. 119:284-294(2006) · UniProtKB (1) · Mapped (2) |
| Induction of apoptosis and activation of NF-kappaB by CD95 require different signalling thresholds. Legembre P., Barnhart B.C., Zheng L., Vijayan S., Straus S.E., Puck J., Dale J.K., Lenardo M., Peter M.E.
EMBO Rep. 5:1084-1089(2004) · Mapped (11) |
| Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Chun H.J., Zheng L., Ahmad M., Wang J., Speirs C.K., Siegel R.M., Dale J.K., Puck J., Davis J., Hall C.G. et al.
Nature 419:395-399(2002) · UniProtKB (1) · Mapped (1) |
| The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Straus S.E., Jaffe E.S., Puck J.M., Dale J.K., Elkon K.B., Roesen-Wolff A., Peters A.M.J., Sneller M.C., Hallahan C.W., Wang J. et al.
Blood 98:194-200(2001) · UniProtKB (1) |
| Lack of interleukin-6 (IL-6) enhances susceptibility to infection but does not alter latency or reactivation of herpes simplex virus type 1 in IL-6 knockout mice. LeBlanc R.A., Pesnicak L., Cabral E.S., Godleski M., Straus S.E.
J. Virol. 73:8145-8151(1999) · Mapped (4) |
| Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Wang J., Zheng L., Lobito A., Chan F.K., Dale J., Sneller M., Yao X., Puck J.M., Straus S.E., Lenardo M.J.
Cell 98:47-58(1999) · UniProtKB (1) |
| Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Jackson C.E., Fischer R.E., Hsu A.P., Anderson S.M., Choi Y., Wang J., Dale J.K., Fleisher T.A., Middelton L.A., Sneller M.C. et al.
Am. J. Hum. Genet. 64:1002-1014(1999) · UniProtKB (1) |
| The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis. Infante A.J., Britton H.A., DeNapoli T., Middelton L.A., Lenardo M.J., Jackson C.E., Wang J., Fleisher T., Straus S.E., Puck J.M.
J. Pediatr. 133:629-633(1998) · UniProtKB (1) |
| Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Sneller M.C., Wang J., Dale J.K., Strober W., Middelton L.A., Choi Y., Fleisher T.A., Lim M.S., Jaffe E.S., Puck J.M. et al.
Blood 89:1341-1348(1997) · UniProtKB (1) |
| Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Fisher G.H., Rosenberg F.J., Straus S.E., Dale J.K., Middleton L.A., Lin A.Y., Strober W., Lenardo M.J., Puck J.M.
Cell 81:935-946(1995) · UniProtKB (1) |
| Varicella-zoster virus complements herpes simplex virus type 1 temperature-sensitive mutants. Felser J.M., Straus S.E., Ostrove J.M.
J. Virol. 61:225-228(1987) · UniProtKB (1) |
| Putative glycoprotein gene of varicella-zoster virus with variable copy numbers of a 42-base-pair repeat sequence has homology to herpes simplex virus glycoprotein C. Kinchington P.R., Remenick J., Ostrove J.M., Straus S.E., Ruyechan W.T., Hay J.
J. Virol. 59:660-668(1986) · UniProtKB (1) |
| Molecular analysis of the pyrimidine deoxyribonucleoside kinase gene of wild-type and acyclovir-resistant strains of varicella-zoster virus. Sawyer M.H., Inchauspe G., Biron K.K., Waters D.J., Straus S.E., Ostrove J.M.
J. Gen. Virol. 69:2585-2593(1988) · UniProtKB (2) |
| Cell lines containing varicella-zoster virus open reading frame 62 and expressing the 'IE' 175 protein complement ICP4 mutants of herpes simplex virus type 1. Felser J.M., Kinchington P.R., Inchauspe G., Straus S.E., Ostrove J.M.
J. Virol. 62:2076-2082(1988) · UniProtKB (1) |
| The nucleotide sequence, 5' end, promoter domain, and kinetics of expression of the gene encoding the herpes simplex virus type 2 latency-associated transcript. Krause P.R., Ostrove J.M., Straus S.E.
J. Virol. 65:5619-5623(1991) · UniProtKB (3) |
| Varicella-zoster virus open reading frame 61 protein is functionally homologous to herpes simplex virus type 1 ICP0. Moriuchi H., Moriuchi M., Smith H.A., Straus S.E., Cohen J.I.
J. Virol. 66:7303-7308(1992) · UniProtKB (1) |
